Subsequent comparative analysis of differentially expressed genes in the TCGA-GBM cohort identified significant enrichment of mutations in RYR2 and HYDIN among tumors with high KLF5 expression (Figure 8E). This evidence concerns the gene RYR2 and glioblastoma.